{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:12:34Z","timestamp":1764785554329,"version":"3.37.3"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117265","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:37:22Z","timestamp":1736397442000},"page":"117265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["[18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors"],"prefix":"10.1016","volume":"286","author":[{"given":"Chris","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Endepols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta A.","family":"Urusova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Elchine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris D.","family":"Zlatopolskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117265_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International union of basic and clinical pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117265_bib2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2174\/138161206777698909","article-title":"Serotonin and human cognitive performance","volume":"12","author":"Schmitt","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2025.117265_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117265_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","article-title":"A review of the role of serotonin receptors in psychiatric disorders","volume":"15","author":"Naughton","year":"2000","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.ejmech.2025.117265_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0920-9964(96)00034-5","article-title":"Decreased frontal cortical serotonin2A receptors in schizophrenia","volume":"21","author":"Dean","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.06.010","article-title":"The serotonergic system in ageing and Alzheimer's disease","volume":"99","author":"Rodr\u00edguez","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117265_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-3940(84)90402-6","article-title":"Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease","volume":"51","author":"Perry","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2025.117265_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-004-2077-2","article-title":"Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer\u2019s disease","volume":"179","author":"Lai","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2025.117265_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pscychresns.2009.03.007","article-title":"Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer\u2019s disease with [18F]deuteroaltanserin and PET","volume":"173","author":"Santhosh","year":"2009","journal-title":"Psychiatry Res. Neuroimaging."},{"key":"10.1016\/j.ejmech.2025.117265_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/brain\/116.3.497","article-title":"Loss of brain 5-HT2 receptors in Alzheimer\u2019s disease. In vivo assessment with positron emission tomography and [18F]setoperone","volume":"116","author":"Blin","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2025.117265_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0197-4580(02)00137-9","article-title":"Imaging of the 5-HT2A system: age-, gender-, and Alzheimer\u2019s disease-related findings","volume":"24","author":"Versijpt","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2025.117265_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib13","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","article-title":"Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907","volume":"163","author":"Bhagwagar","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0006-3223(98)00132-2","article-title":"The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis","volume":"44","author":"Kroeze","year":"1998","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib15","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117265_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/da.20087","article-title":"Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein","volume":"22","author":"Cohen","year":"2005","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejmech.2025.117265_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1176\/ajp.156.1.72","article-title":"Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects","volume":"156","author":"Lewis","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib18","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/S0024-3205(00)80005-3","article-title":"Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography","volume":"66","author":"Okubo","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117265_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(98)00014-0","article-title":"No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET","volume":"31","author":"Trichard","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/appi.ajp.157.6.1016","article-title":"Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [18F]setoperone","volume":"157","author":"Ngan","year":"2000","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal Serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib22","first-page":"2266","article-title":"Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats","volume":"32","author":"Lemaire","year":"1991","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-8993(98)00909-3","article-title":"Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction","volume":"813","author":"Meltzer","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.WCB.0000126233.08565.E7","article-title":"[18F]Altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge","volume":"24","author":"Pinborg","year":"2004","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2025.117265_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12917-019-2165-5","article-title":"Kinetic analysis of [18F]altanserin bolus injection in the canine brain using PET imaging","volume":"15","author":"Pauwelyn","year":"2019","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1471-4159.1990.tb01229.x","article-title":"A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone","volume":"54","author":"Blin","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.117265_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/appi.neuropsych.11080202","article-title":"5-HT2 receptor distribution shown by [18F]setoperone PET in high-functioning autistic adults","volume":"24","author":"Beversdorf","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117265_bib28","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ajp.156.7.1029","article-title":"Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study","volume":"156","author":"Meyer","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0006-3223(98)00007-9","article-title":"The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine","volume":"45","author":"Attar-L\u00e9vy","year":"1999","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib30","first-page":"208","article-title":"PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907","volume":"39","author":"Ito","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.biopsych.2011.06.023","article-title":"Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907","volume":"70","author":"Simpson","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117265_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0969-8051(99)00022-0","article-title":"Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent","volume":"26","author":"Tan","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.117265_bib33","series-title":"Drugs as Tools Neurotransmitter Res.","first-page":"299","article-title":"Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites","author":"Leysen","year":"1989"},{"key":"10.1016\/j.ejmech.2025.117265_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(88)90635-8","article-title":"[18F]Setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo","volume":"147","author":"Blin","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117265_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jlcr.1563","article-title":"Synthesis, radiofluorination and first evaluation of (\u00b1)-[18F]MDL 100907 as serotonin 5-HT2A receptor antagonist for PET","volume":"52","author":"M\u00fchlhausen","year":"2009","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2025.117265_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/cn500078e","article-title":"Synthesis and imaging validation of [18F]MDL100907 enabled by Ni-mediated fluorination","volume":"5","author":"Ren","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117265_bib37","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1021\/acschemneuro.3c00382","article-title":"Concise and scalable radiosynthesis of (+)-[18F]MDL100907 as a serotonin 5-HT2A receptor antagonist for PET","volume":"14","author":"Chavan","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117265_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nucmedbio.2010.02.002","article-title":"18F-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging","volume":"37","author":"Debus","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.117265_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00259-019-04527-w","article-title":"Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain","volume":"47","author":"Kramer","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.117265_bib40","series-title":"5-HT2A Recept. Cent. Nerv. Syst.","first-page":"85","article-title":"PET imaging of the 5-HT2A receptor system: a tool to study the receptor\u2019s in vivo brain function","author":"Herth","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117265_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000321594","article-title":"P-glycoprotein influence on the brain uptake of a 5-HT2A ligand: [18F]MH.MZ","volume":"63","author":"Schmitt","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejmech.2025.117265_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jlcr.2580340902","article-title":"Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for \u03b3-emission tomography","volume":"34","author":"Mertens","year":"1994","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2025.117265_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0969-8051(95)02023-3","article-title":"Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide as a potential 5HT2 receptor tracer for SPE(C)T","volume":"22","author":"Terriere","year":"1995","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.117265_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brs.2010.09.002","article-title":"The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression","volume":"4","author":"Baeken","year":"2011","journal-title":"Brain Stimul."},{"key":"10.1016\/j.ejmech.2025.117265_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2967\/jnumed.108.055731","article-title":"Evaluation of the brain 5-HT2A receptor binding index in dogs with anxiety disorders, measured with 123I-5I-R91150 and SPECT","volume":"50","author":"Vermeire","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MNM.0b013e3282fdc989","article-title":"Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain","volume":"29","author":"Peremans","year":"2008","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ejmech.2025.117265_bib47","first-page":"163","article-title":"Decreased 5-HT2a receptor binding in patients with anorexia nervosa","volume":"44","author":"Audenaert","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1192\/bjp.173.3.236","article-title":"5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine","volume":"173","author":"Travis","year":"1998","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117265_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JPD-130300","article-title":"Changes in 5-HT2A Receptor Expression in Untreated, de novo Patients with Parkinson\u2019s Disease","volume":"4","author":"Melse","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejmech.2025.117265_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jlcr.1565","article-title":"Synthesis, labelling and first evaluation of [18F]R91150 as a serotonin 5-HT2A receptor antagonist for PET","volume":"52","author":"M\u00fchlhausen","year":"2009","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2025.117265_bib51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/acsmedchemlett.0c00658","article-title":"Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET-imaging","volume":"12","author":"Willmann","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117265_bib52","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1021\/ol501243g","article-title":"Copper-catalyzed [18F]fluorination of (Mesityl)(aryl)iodonium salts","volume":"16","author":"Ichiishi","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117265_bib53","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1002\/anie.201404436","article-title":"A general copper-mediated nucleophilic 18F fluorination of arenes","volume":"53","author":"Tredwell","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117265_bib54","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/acs.orglett.5b02875","article-title":"Synthesis of [18F]arenes via the copper-mediated [18F]fluorination of boronic acids","volume":"17","author":"Mossine","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117265_bib55","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/acs.orglett.6b02911","article-title":"Copper-mediated radiofluorination of arylstannanes with [18F]KF","volume":"18","author":"Makaravage","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117265_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202202965","article-title":"Next generation copper mediators for the efficient production of 18F\u2010labeled aromatics","volume":"29","author":"Hoffmann","year":"2023","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117265_bib57","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/chem.201604633","article-title":"Alcohol-enhanced Cu-mediated radiofluorination","volume":"23","author":"Zischler","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117265_bib58","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1016\/j.bmc.2014.05.066","article-title":"Synthesis of new compounds with promising antiviral properties against group A and B Human Rhinoviruses","volume":"22","author":"Bernard","year":"2014","journal-title":"Bioorg. Med. Chem."},{"author":"Hudkins","key":"10.1016\/j.ejmech.2025.117265_bib59"},{"key":"10.1016\/j.ejmech.2025.117265_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113214","article-title":"Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A2A receptor ligands","volume":"214","author":"Renk","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117265_bib61","first-page":"G877","article-title":"5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice","volume":"282","author":"Fiorica-Howells","year":"2002","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.ejmech.2025.117265_bib62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.orcp.2016.03.015","article-title":"5-HT2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats","volume":"12","author":"Li","year":"2018","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2025.117265_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2010.00036","article-title":"Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice","author":"Weber","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117265_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib65","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","article-title":"Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907","volume":"356","author":"L\u00f3pez-Gim\u00e9nez","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117265_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S8756-3282(01)00593-2","article-title":"Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake","volume":"29","author":"Bliziotes","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2025.117265_bib67","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bone.2006.06.009","article-title":"Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells","volume":"39","author":"Bliziotes","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2025.117265_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20734","article-title":"Serotonin and fluoxetine modulate bone cell function in vitro","volume":"98","author":"Gustafsson","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2025.117265_bib69","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117265_bib70","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0028-3908(95)00138-7","article-title":"Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera","volume":"34","author":"Abramowski","year":"1995","journal-title":"Neuropharmacology"},{"year":"1994","series-title":"4-Amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides","author":"Leysen","key":"10.1016\/j.ejmech.2025.117265_bib71"},{"key":"10.1016\/j.ejmech.2025.117265_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jnr.10072","article-title":"Serotonin 5-HT2C receptor knockout mice: autoradiographic analysis of multiple serotonin receptors","volume":"67","author":"L\u00f3pez\u2010Gim\u00e9nez","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejmech.2025.117265_bib73","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuroimage.2013.08.035","article-title":"Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain","volume":"84","author":"Finnema","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejmech.2025.117265_bib74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117265_bib75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12987-022-00335-x","article-title":"Transcriptional profiling of transport mechanisms and regulatory pathways in rat choroid plexus","volume":"19","author":"Andreassen","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejmech.2025.117265_bib76","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","article-title":"Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood\u2013cerebrospinal-fluid drug-permeability barrier","volume":"96","author":"Rao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117265_bib77","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2967\/jnumed.108.058453","article-title":"Human brain imaging and radiation dosimetry of 11C-N-Desmethyl-Loperamide, a PET radiotracer to measure the function of P-glycoprotein","volume":"50","author":"Seneca","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib78","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s12149-021-01666-9","article-title":"First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood\u2013brain barrier","volume":"35","author":"Toyohara","year":"2021","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117265_bib79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/cmdc.201000067","article-title":"A series of 18F\u2010labelled pyridinylphenyl amides as subtype\u2010selective radioligands for the dopamine D3 receptor","volume":"5","author":"Hocke","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117265_bib80","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jcbfm.2014.68","article-title":"Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36","volume":"34","author":"Ettrup","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejmech.2025.117265_bib81","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/jm0301742","article-title":"Synthesis and pharmacological evaluation of 1-Oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing If channel inhibitory activity","volume":"46","author":"Kubota","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117265_bib82","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1021\/jo200917d","article-title":"Oligophenylenaminones as scaffolds for \u03b1-helix mimicry","volume":"76","author":"Adler","year":"2011","journal-title":"J. Org. Chem."},{"year":"2020","series-title":"Inhibitor Containing Bicyclic Derivative, Preparation Method Therefor and Use Thereof","author":"Su","key":"10.1016\/j.ejmech.2025.117265_bib83"},{"key":"10.1016\/j.ejmech.2025.117265_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123847","article-title":"Validation of analytical HPLC with post-column injection as a method for rapid and precise quantification of radiochemical yields","volume":"1228","author":"Humpert","year":"2023","journal-title":"J. Chromatogr. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:06:57Z","timestamp":1740380817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":84,"alternative-id":["S0223523425000303"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117265","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117265"}}